Apyx Medical Corp Total Assets

• Apyx Medical Corp showed an increase of +3.1% in Total Assets from 2024 to 2025.
• This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2010 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2011: $28.65 million | Q3 2011: $28.55 million | Q1 2012: $27.99 million | Q2 2012: $28.04 million | Q3 2012: $28.04 million | Q1 2013: $28.08 million | Q2 2013: $27.93 million | Q3 2013: $27.69 million | Q1 2014: $32.51 million | Q2 2014: $31.60 million | Q3 2014: $31.29 million | Q1 2015: $34.59 million | Q2 2015: $34.13 million | Q3 2015: $33.12 million | Q1 2016: $29.75 million | Q2 2016: $29.59 million | Q3 2016: $29.15 million | Q1 2017: $33.09 million | Q2 2017: $32.56 million | Q3 2017: $30.70 million | Q1 2018: $30.11 million | Q2 2018: $30.65 million | Q2 2019: $88.88 million | Q3 2019: $86.94 million | Q1 2020: $82.12 million | Q2 2020: $77.83 million | Q3 2020: $75.42 million | Q1 2021: $71.10 million | Q2 2021: $69.60 million | Q3 2021: $67.77 million | Q1 2022: $63.00 million | Q2 2022: $59.47 million | Q3 2022: $55.27 million | Q1 2023: $56.78 million | Q2 2023: $62.43 million | Q3 2023: $59.45 million | Q1 2024: $70.71 million | Q2 2024: $65.39 million | Q3 2024: $60.72 million | Q1 2025: $60.16 million | Q2 2025: $58.19 million | Q3 2025: $57.37 million.
• Over the full 18 years of available data (2010 to 2025), Apyx Medical Corp's Total Assets has grown by 140.6%.
• Historical annual values: Fiscal year 2025: $66.84 million | Fiscal year 2024: $64.84 million | Fiscal year 2023: $79.24 million | Fiscal year 2022: $51.78 million | Fiscal year 2021: $68.72 million | Fiscal year 2020: $74.11 million | Fiscal year 2019: $84.75 million | Fiscal year 2019: $91.86 million | Fiscal year 2018: $95.93 million | Fiscal year 2018: $113.17 million | Fiscal year 2017: $30.99 million | Fiscal year 2016: $35.11 million | Fiscal year 2015: $31.45 million | Fiscal year 2014: $24.83 million | Fiscal year 2013: $33.18 million | Fiscal year 2012: $28.18 million | Fiscal year 2011: $28.24 million | Fiscal year 2010: $27.79 million.
• Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: August 4, 2026